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Background: Betablockers are frequently used in patients of mitral stenosis (MS) to alleviate symptoms. Present study tested the hypothesis that 
heart rate (HR) reduction with Ivabradine ((I) would have the same clinical & haemodynamic benefits as metoprolol (M) in patients with mild to 
moderate MS in sinus rhythm.
Methods and Results: 33 patients (15 males, Mean age 28.8 yrs) of MS (mean MVA 1.57± 0.17 cm2) in normal sinus rhythm and NYHA II were 
included in study. Clinical assessment, Treadmill stress testing (TMT) and echo-Doppler evaluation was done to see resting HR, mean gradient across 
MV, mean pulmonary artery systolic pressure (PASP), Total Exercise Duration (TED) & peak exercising HR. Patients were then allocated to either M 
or I to maximal tolerated doses for 6 weeks (M: 100mg BID, I: 10 mg BID). After two-week drug washout interval, two groups were crossed over to 
alternate drug for another 6 weeks. Evaluation of parameters was done at end of both six weeks periods. All patients remained in normal sinus 
rhythm and were in NYHA class I at end of study.Results are in table below.
Conclusions: Ivabradine decreases resting HR and is as effective as metoprolol in increasing exercise duration, reducing transmitral gradient and 
PASP in mild to moderate MS with normal sinus rhythm.
Parameters Baseline(Mean±SD) Metoprolol (Mean±SD) p value Ivabradine (Mean±SD) p value p value, M vs I
HR (BPM)
Resting
Exercise
103.5±7.2
172.5±23.7
61.8 ±3.8
130.3±24.1
0.001
0.001
65.9 ±5.7
132.9±24.3
0.001
0.001
NS
NS
MG (mmHg) 10.6±1.6 6.3 ±1.7 0.006 6.0 ±1.6 0.001 NS
PASP (mmHg) 38.1±5.1 27.7 ±4.4 0.004 28.4 ±4.2 0.006 NS
TED (min) 7.9±1.6 10.3 ±1.7 0.001 10.6 ±1.6 0.002 NS
